UNC Hospitals, The University of North Carolina at Chapel Hill is a clinical research site located in Chapel Hill, North Carolina, United States 27514.
Crixeo Clinical Trials Trust Score: 94/100 (GOOD). This profile has not yet been claimed by the site owner.
UNC Hospitals, The University of North Carolina at Chapel Hill has participated in 24 clinical trials with 11 currently active.
Therapeutic areas: Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma, Breast Cancer Metastatic.
Sponsors: Pfizer, Seagen, a wholly owned subsidiary of Pfizer, AIDS Malignancy Consortium.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in North Carolina · View every site in Chapel Hill
Trust Score: 94/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
UNC Hospitals, The University of North Carolina at Chapel Hill has a Crixeo Trust Score of 94/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UNC Hospitals, The University of North Carolina at Chapel Hill has 24 clinical trials on record, with 11 currently active. Their work covers Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma, Breast Cancer Metastatic.
UNC Hospitals, The University of North Carolina at Chapel Hill has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.